P Tolås

Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?

Frode Lerang, Bjørn Moum, Jon Birger Haug et al. · PubMed · 1997 · 79 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.

Frode Lerang, Bjørn Moum, E Ragnhildstveit et al. · PubMed · 1997 · 31 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Highly Effective Second-Line Anti<i>-Helicobacter pylori</i>Therapy in Patients with Previously Failed Metronidazole-Based Therapy

Frode Lerang, Bjørn Moum, Jon Birger Haug et al. · Scandinavian Journal of Gastroenterology · 1997 · 27 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Simplified 10-Day Bismuth Triple Therapy for Cure of Helicobacter pylori Infection: Experience From Clinical Practice in a Population With a High Frequency of Metronidazole Resistance

Frode Lerang, Bjoern Mourn, E Ragnhildstveit et al. · The American Journal of Gastroenterology · 1998 · 24 citations

Pharmacy, Pharmacology, Pharmacotherapy +13